Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1982-03-01
1983-05-03
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
536 72, A61K 3170, C07H 178
Patent
active
043820867
ABSTRACT:
Antibacterial macrolides derived from 9-dihydro-11,12-O-isopropylidene-erythromycin A and 9-dihydro-11,12-O-isopropylidene-4"-epi-erythromycin A.
REFERENCES:
patent: 2653899 (1953-09-01), Bunch et al.
patent: 3417077 (1968-12-01), Murphy et al.
patent: 3884903 (1975-05-01), Jones et al.
patent: 4150220 (1979-04-01), Sciavolino
K. Gerzon et al., and M. V. Sigal et al., J. Am. Chem. Soc., 78, 6396, (1956).
Hauske James R.
Sciavolino Frank C.
Brown Johnnie R.
Frost Albert E.
Knuth Charles J.
McManus James M.
Pfizer Inc.
LandOfFree
9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-eryt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-eryt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-eryt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1208977